Purpose: Ketamine-propofol combination (ketofol) is being used to provide a safe and effective procedural sedation (PS) in emergency department (ED) and may theoretically have beneficial effects since using lower doses of each drug may result in a reduction of the adverse events of both agents while maintaining optimal conditions for performing procedures. This systematic review was conducted to evaluate the efficacy, advantages and disadvantages of these two drugs for PS. Methods: The PRISMA statement was used for this systematic review. We searched the databases of PubMed, Scopus, ProQuest, Medline (Ovid) from 1990 to August 2017 for randomized clinical trials (RCTs) in which the study population aged ≥18 and was referred to ED. Full-texts of the studies performed in adults that were published in English were reviewed for inclusion. Both authors independently evaluated all studies. Five articles were eligible for the meta-analysis based on their common outcomes. Results: The total number of subjects was 1250, of which 635 were treated with propofol and 615 were treated with ketofol. Although two of the five studies showed a better quality of sedation with ketofol, the other three did not find any significant difference between propofol and ketofol. This systematic review found a lower incidence of respiratory adverse effects in ketofol group than propofol group. Conclusion: Ketamine/propofol mixture (ketofol) has less respiratory adverse effects than propofol alone in ED procedural sedation.
Etomidate is an imidazole derivative that is widely used in the emergency department for Rapid Sequence Intubation (RSI). Although it has a safe hemodynamic profile, there are some concerns about its suppressant effects on the adreno-cortical axis. Vitamin C, as an antioxidant, can play a protective role in this issue. In a controlled clinical trial, we studied adult traumatic patients who needed RSI with etomidate. In one group underwent RSI with etomidate and cortisol levels were measured three hours later. In the other group, we administered one gram of vitamin C before etomidate administration, and the cortisol level was measured three hours later. Fifty-one patients have been studied. The serum cortisol level was significantly lower after RSI with etomidate in both groups. In the Vitamin C group, there was a significantly higher cortisol level after RSI in comparison to the control group. Etomidate can suppress the cortisol level in trauma patients who undergo RSI. Vitamin C can reduce this suppressant effect of etomidate. IRCT registration number: IRCT20090923002496N11, URL of trial registry record: https://en.irct.ir/trial/34586, Date of trial registration: 19/04/2019. Full date of the first registration: 30/05/2019.
Introduction: Acute chest pain is an important and frequently occurring symptom in patients. Chest pain is often a sign of ischemic heart disease. Associated findings of electrocardiograph (ECG) are rather heterogeneous, and traditional cardiac biomarkers such as Creatine Kinase-MB (CK-MB) suffer from low cardiac specificity and sensitivity. In this study cost effectiveness of cardiac biomarkers single quantitative measurement was examined.
25 September 2015 in Journal of Emergency Practice and Trauma
Worldwide trauma is currently the sixth leading cause of death, according to 10% of mortalities (1,2). Injury impact and the death from trauma are more common in males than females. People aged between 15 and 45 years include about half of the trauma deaths (3). Citizens of low-and middle-income countries (LMICs) account for 89% of all deaths from trauma worldwide. This is particularly because of hospitals' lack of facilities, equipments, and peripheral care systems (4,5). During last year since the 20th of March 2013 until the 20th of March 2014, 27 740 traumatic patients were admitted to Iran's North West Trauma Center (Emam Reza hospital) in which 105 patients were expired in emergency, surgery, and neurosurgery departments. This included 11 female patients (10%) and 94 male patients (90%) (Figure 1). According to previous studies, motor vehicle accidents are the most common reason of multitrauma. Researchers highlight that in developing countries, trauma is the leading cause of death for young people (6). In our study, the reports show that the causes of injury that led to death in 71 patients were motor vehicle crash, in 25 patients falling from a high altitude, one patient because of pedestrian motor vehicle accident, and 8 patients because of fighting (Figure 2). Seventy-five patients in morning shifts (8 am to 8 pm) and 30 patients in night shifts (8 pm to 8 am) were admitted. Approximately about 30 patients in spring, 34 patients in summer, 25 patients in fall and 18 patients in winter experienced traumatic injury leading to death.